Hirano Daishi, Inoue Eisuke, Sako Mayumi, Ashida Akira, Honda Masataka, Takahashi Shori, Iijima Kazumoto, Hattori Motoshi
Department of Pediatrics, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.
Showa University Research Administration Center, Showa University, Tokyo, Japan.
Pediatr Nephrol. 2023 Jan;38(1):1-7. doi: 10.1007/s00467-022-05568-4. Epub 2022 Apr 30.
Limited data are available on the survival and causes of death in pediatric patients with chronic kidney disease (CKD) stage 5 receiving kidney replacement therapy (KRT) in Asia.
Data were obtained from the Japanese nationwide cross-sectional CKD stage 5 survey on pediatric patients (<20 years of age) who started KRT from 2006 to 2013. The cohort was divided into three groups according to age at the start of KRT: <1, 1-5, and 6-19 years.
Among the 701 children who were included, 59.3% were boys. Peritoneal dialysis was the most common initial modality of KRT (60.3%). Median age at KRT initiation was 10.2 years. Infants (<1 year old) accounted for 16.0% of the total cohort. Overall survival at 1 and 5 years was 97.2% and 92.5%, respectively. Infants had significantly lower survival rates than the other groups (hazard ratio, 5.35; 95% CI, 2.60-11.03; P < 0.001). In contrast, after the age of 1 year, the survival rate improved and did not differ from that of other age groups. The most common causes of death were infection (35.9%) and sudden death (15.4%).
The overall survival rate of pediatric patients with CKD stage 5 in Japan is like that in other high-income countries. Age at initiation of KRT is an important factor affecting survival since the poorest survival rate was observed in infants. Further improvement in infant dialysis therapy is still needed to improve survival of the youngest children. A higher resolution version of the Graphical abstract is available as Supplementary information.
在亚洲,关于接受肾脏替代治疗(KRT)的慢性肾脏病(CKD)5期儿科患者的生存率和死亡原因的数据有限。
数据来自日本全国性的关于2006年至2013年开始接受KRT的儿科患者(<20岁)的CKD 5期横断面调查。根据开始KRT时的年龄,该队列分为三组:<1岁、1 - 5岁和6 - 19岁。
纳入的701名儿童中,59.3%为男孩。腹膜透析是最常见的初始KRT方式(60.3%)。开始KRT的中位年龄为10.2岁。婴儿(<1岁)占总队列的16.0%。1年和5年的总生存率分别为97.2%和92.5%。婴儿的生存率明显低于其他组(风险比,5.35;95%可信区间,2.60 - 11.03;P < 0.001)。相比之下,1岁以后,生存率有所提高,与其他年龄组没有差异。最常见的死亡原因是感染(35.9%)和猝死(15.4%)。
日本CKD 5期儿科患者的总体生存率与其他高收入国家相似。开始KRT的年龄是影响生存的一个重要因素,因为婴儿的生存率最低。仍需要进一步改善婴儿透析治疗以提高最小儿童的生存率。更高分辨率的图形摘要版本可作为补充信息获取。